Urticaria
📧 Sign up to get email alerts when something new happens for Urticaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2026-07-30FDA Approved: FEXOFENADINE HYDROCHLORIDE — Original Application (DR REDDYS)
FDA approval information for the original application of fexofenadine hydrochloride (generic antihistamine) by Dr. Reddy's.
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine Actavis (desloratadine) — Actavis Group PTC ehf
Authorised Desloratadine Actavis (desloratadine) for allergic rhinitis and urticaria in the EU.
-
EMA approval · 2026-07-10EMA Authorised: Desloratadine ratiopharm (desloratadine) — Ratiopharm GmbH
Authorised desloratadine product from Ratiopharm (desloratadine) for allergic rhinitis and urticaria indications in the EU.
-
EMA approval · 2026-06-08EMA Authorised: Xolair (omalizumab) — Novartis Europharm Limited
EMA has authorised Xolair (omalizumab) for indications including asthma, urticaria, and rhinitis, under the MAH Novartis Europharm Limited.
-
EMA approval · 2026-06-05EMA Authorised: Dasselta (desloratadine) — Krka, d.d., Novo mesto
Dasselta (desloratadine) by Krka has been authorised for allergic rhinitis (perennial and seasonal) and urticaria in the EU.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2026-03-24FDA Approved: ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approved a supplemental application for ZYRTEC (cetirizine hydrochloride) filed by Kenvue Brands LLC. This action confirms regulatory ap…
-
EMA approval · 2026-03-19EMA Authorised: Neoclarityn (desloratadine) — Organon N.V.
The EMA authorised Neoclarityn (desloratadine) by Organon N.V. for allergic rhinitis (perennial and seasonal) and urticaria.
-
EMA approval · 2026-03-19EMA Authorised: Aerius (desloratadine) — Organon N.V.
The European Medicines Agency has authorised Aerius (desloratadine), a non-sedating antihistamine for allergic rhinitis (perennial and seaso…
-
FDA approval · 2026-03-05FDA Approved: CHILDRENS XYZAL ALLERGY — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for Children's XYZAL Allergy (levocetirizine dihydrochloride) from Chattem, Inc., signaling a la…
-
EMA approval · 2026-03-02EMA Authorised: Azomyr (desloratadine) — Organon N.V.
The European Medicines Agency authorised Azomyr, a desloratadine-containing medicine by Organon N.V., for allergic rhinitis (seasonal and pe…
-
FDA approval · 2026-02-25FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Advagen Pharma Ltd.,)
FDA approved cetirizine hydrochloride via Original Application (ANDA) for Advagen Pharma Ltd.
-
FDA approval · 2026-01-30FDA Approved: CETIRIZINE HCL — Supplemental Application (AMERISOURCE BERGEN)
The FDA approved a supplemental application for cetirizine hydrochloride, submitted by Amerisource Bergen.
-
FDA approval · 2025-12-24FDA Approved: CHILDRENS ZYRTEC — Supplemental Application (Kenvue Brands LLC)
FDA approves a supplemental application for Children's ZYRTEC (cetirizine hydrochloride) to update labeling/indications submitted by Kenvue …
-
FDA approval · 2025-11-25FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (BAJAJ MEDICAL, LLC)
FDA approved a supplemental application for cetirizine hydrochloride from Bajaj Medical, LLC, authorizing continued marketing of the generic…
-
EMA approval · 2025-11-18EMA Authorised: Omlyclo (omalizumab) — Celltrion Healthcare Hungary Kft.
EMA has authorised Omlyclo (omalizumab) by Celltrion Healthcare Hungary Kft. for asthma and urticaria.
-
FDA approval · 2025-08-29FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Rising Pharma Holdings, Inc., indicating an update to the approved…
-
FDA approval · 2025-08-22FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved a Diphenhydramine hydrochloride product from Micro Labs Limited under Original Application (ANDA 219845). This approval covers …
-
FDA approval · 2025-08-01FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Sandoz Inc)
The FDA approved a supplemental application for cetirizine hydrochloride from Sandoz Inc, granting regulatory clearance for this generic ant…
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Chartwell RX, LLC)
FDA approved a supplemental application for levocetirizine dihydrochloride (generic) submitted by Chartwell RX, LLC.
-
FDA approval · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for cetirizine hydrochloride from Padagis Israel Pharmaceuticals Ltd, confirming approval under a su…
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Teva's levocetirizine dihydrochloride under an ANDA. The notice indicates an approved supplement…
-
FDA approval · 2025-07-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Rising Pharma Holdings, Inc.
-
FDA approval · 2025-07-11FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' supplemental application for levocetirizine dihydrochloride, a generic antihistamine, under an ANDA.
-
EMA approval · 2025-05-28EMA Authorised: Xolair (omalizumab) — Novartis Europharm Limited
The European Medicines Agency authorised Xolair (omalizumab) for asthma, urticaria, and rhinitis with Novartis Europharm Limited as the mark…
-
FDA approval · 2025-05-14FDA Approved: CLARITIN CHEWABLE GRAPE AND BUBBLEGUM — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application to add a new chewable grape and bubblegum formulation of loratadine (Claritin) by Bayer HealthCare L…